Barriers and facilitators to insulin treatment: a phenomenological inquiry

ConclusionsMarket failures due to supply shortages and associated costs were identified to be the most significant barriers to insulin treatment, necessitating the availability of an effective pharmaceutical supply management strategy that targets on insulin supply and affordability. It is also strongly recommended that health insurance coverage be increased.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research